TT  Cornell Center for Technology Licensing

http://www.ctl.cornell.edu/





     Office Locations:

395 Pine Tree Road, Suite 310
Ithaca, NY 14850
Phone: 607-254-4698
Fax: 607-254-5454

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Seed


 

Industries:

  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare
  • Semiconductor

  •  

    Description:

    The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. The Center manages technology for Cornell's Ithaca campus, Weill Cornell Medical Colleges, Cornell Tech and the New York State Agricultural Experiment Station in Geneva. CTL's mission is to bring the University's scientific discoveries, technological innovations, and medical advances to the marketplace for societal benefit and to foster economic development within New York State and across the nation. CTL manages inventions from disciplines including, but not limited to, chemistry, engineering, information technologies, materials science, medicine, plant science, and veterinary medicine. CTL licenses Cornell technologies to industry partners from all 50 states and in Europe, Asia-Pacific, the Middle East, and Central and South America. Cornell inventions are patented in over forty countries. $1.9 billion has been raised by startups.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Alice Li PhD, CLP Executive Director
    Brian Kelly PhD Director, Technology Licensing
    Dan-Oscar Antson PhD Technology Licensing Officer
    Iris Bica Business Development and Licensing Associate
    Martin Teschl CLP, MS Director, Business Development & Licensing

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/17/2024


      Ratio Therapeutics


      MA


      $50,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: